Cold atmospheric plasma plus endovascular treatment for diabetic foot ulcers with blocked lower‑leg arteries
Official title: Efficacy and Safety of Cold Atmospheric Plasma Combined With Endovascular Intervention in Patients With Diabetic Foot Ulcers and Lower Extremity Arterial Occlusion: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Run by Shenyang Medical College · NCT07073040 · Data updated 2026-11-12
This will test whether adding cold atmospheric plasma after successful endovascular angioplasty helps heal diabetic foot ulcers in adults with lower‑leg arterial blockages.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 86 (estimated) |
| Sponsor | Shenyang Medical College Academic / other |
| Locations | 1 site (Anshan, Liaoning) |
| Status | Recruiting |
| Started | July 22, 2025 |
| Main results expected | April 10, 2026 |
| Study ends | May 6, 2026 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT07073040 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with type 1 or 2 diabetes, an HbA1c ≤10%, a chronic foot ulcer (≥3 weeks) classified as Wagner‑Armstrong 1D or 2D, documented infrapopliteal stenosis/occlusion who have received successful infrapopliteal balloon angioplasty, and who provide informed consent are ideal candidates.
✕Probably not a fit
Patients receiving other local advanced wound therapies (for example vacuum‑assisted closure or maggot therapy), those who do not achieve successful revascularization, or those with wounds unsuitable for topical CAP application are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls adults with diabetes who have chronic foot ulcers and documented infrapopliteal arterial stenosis or occlusion who undergo successful infrapopliteal balloon angioplasty. After confirming arterial patency by intraoperative angiography, participants receive either cold atmospheric plasma treatment to the ulcer or a sham procedure in addition to standard wound care. The goal is to determine whether the local application of cold atmospheric plasma improves microvascular perfusion and accelerates wound healing beyond revascularization alone. Outcomes will include wound healing measures and safety endpoints over a defined follow‑up period.
Why it matters
Potential benefit: If successful, the combined approach could speed ulcer healing, reduce the need for amputations, and improve limb salvage in people with ischemic diabetic foot ulcers.
How similar studies have gone: Small pilot studies and early clinical reports suggest cold atmospheric plasma can promote wound healing, but combining CAP with endovascular revascularization is a relatively novel approach without large randomized trial confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18-80 years, with a diagnosis of type 1 or type 2 diabetes and diabetic foot ulcer; glycated hemoglobin (HbA1c) ≤ 10%. * Presence of at least one chronic foot ulcer persisting for at least three weeks, with no signs of healing after standard-of-care treatment based on current clinical guidelines. The ulcer must be classified as Wagner-Armstrong grade 1D or 2D (Wagner: superficial ulcer \[grade 1\] or ulcer extending to tendon \[grade 2\]; Armstrong: presence of both ischaemia and infection \[stage D\]). * Documented infrapopliteal arterial stenosis or occlusion by vascular ultrasound and/or CT angiography (CTA), meeting indications for revascularization. All enrolled patients must have received successful infrapopliteal balloon angioplasty, with intraoperative angiography confirming target artery patency. * Provision of written informed consent. Exclusion Criteria: * Concurrent treatment of the wound with local vacuum therapy or maggot therapy. * Undergoing dialysis. * Use of local active antibiotics. * Treatment with platelet-rich fibrin. * Women of childbearing potential without effective contraception, or women who are actively breastfeeding. * Presence of other severe organ dysfunction, with an expected survival of less than six months. * Participation in another clinical trial within the past three months or currently enrolled in another clinical trial.
Where it's running
-
Ansteel General Hospital
Anshan, Liaoning, China Recruiting
Study contacts
- Principal investigator: Lin Tao, MM — Shenyang Medical College
- Study coordinator: Yun-En Liu, MD
- Email: lye9901@163.com
- Phone: 86-24-62215130
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cold atmospheric plasma plus endovascular treatment for diabetic foot ulcers with lower-leg artery blockages
This will test whether adding cold atmospheric plasma after endovascular revascularisation helps heal diabetic foot ulcers in adults with lower-extremity arterial occlusion.
-
How long healed diabetic foot ulcers stay closed after CAMPX treatment
This follow-up tests whether diabetic foot ulcers that fully closed by 12 weeks in the CAMPX trial stay closed over a year using home photographic and thermal scans with the BlueDrop OneStep Foot Scanner.
-
Combination Bionerv E+ vs Vitamin B Complex in Type 2 Diabetes with DSPN and Foot Ulcers
In people with type 2 diabetes and diabetic polyneuropathy, this study tests whether adding alpha-lipoic acid and vitamin E to a vitamin B mix helps nerve symptoms and wound healing better than the vitamin B mix alone.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Wound gel for diabetic foot ulcers compared with standard care
This study tests whether the investigational VES-0-D wound gel helps heal mild to moderate diabetic foot ulcers better than standard treatment.
-
High-Purity Collagen Skin Substitute vs Fish Skin Matrix for Diabetic Foot Ulcers
This study tests whether a high-purity type-I collagen skin substitute works better than an acellular fish-skin matrix, when added to standard wound care, for healing diabetic foot ulcers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.